The 38th International Conference on Antiviral Research (ICAR 2025) is dedicated to the latest advancements and breakthroughs in antiviral research.
Topics
- Broad Spectrum Antiviral Drugs, Non-respiratory Biothreat Viruses, and Pandemic Preparedness
- Arboviruses
- Coronaviruses, Influenza, RSV, and Other Respiratory Viruses
- Chronic, Latent, and Persistent Viruses - Retroviruses and Herpesviruses
- Hepatotropic and GI Viruses
Who should Attend
Scientists, researchers, and industry professionals from:
- Startups
- Academia
- Industry
- Small, medium and large pharmaceutical companies
- Governmental and nongovernmental organizations
- Areas of critical importance for immediate or future antiviral development
